- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06195826
Gravity Versus Pump Infusion of Distending Media for Hysteroscopic Myomectomy
January 5, 2024 updated by: Sheng-Mou Hsiao, Far Eastern Memorial Hospital
Gravity Versus Pump Infusion of Distending Media for Hysteroscopic Myomectomy: A Retrospective Cohort Study
To compare the perioperative outcome between the gravity versus pump infusion groups in women who received hysteroscopic myomectomy
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Taipei
-
Banqiao, New Taipei, Taiwan, 22050
- Recruiting
- Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
-
Contact:
- Sheng-Mou Hsiao, M.D.
- Phone Number: 1818 +886-2-89667000
- Email: smhsiao2@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who received hysteroscopic myomectomy
Description
Inclusion Criteria:
- >20 years old women
- women who received hysteroscopic myomectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
gravity infusion
women who received hysteroscopic myomectomy with gravity infusion method
|
hysteroscopic myomectomy with the gravity infusion method
|
|
pump infusion
women who received hysteroscopic myomectomy with pump infusion method
|
hysteroscopic myomectomy with the pump infusion method
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infusion volume of distension medium
Time Frame: 1 week
|
Infusion volume (mL) of distension medium in the uterine cavity between the gravity and pump infusion methods for hysterosopic myomectomy
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative blood loss
Time Frame: 1 week
|
Intraoperative blood loss (mL) between the gravity and pump infusion methods for hysterosopic myomectomy
|
1 week
|
|
Postoperative pain
Time Frame: 1 week
|
Postoperative pain (visual analogue scale 0-10) in the recovery room between the gravity versus pump infusion methods for hysterosopic myomectomy.
|
1 week
|
|
Surgical time
Time Frame: 1 week
|
Surgical time (minutes) between the gravity versus pump infusion methods for hysterosopic myomectomy
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 21, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
December 5, 2023
First Submitted That Met QC Criteria
January 5, 2024
First Posted (Estimated)
January 8, 2024
Study Record Updates
Last Update Posted (Estimated)
January 8, 2024
Last Update Submitted That Met QC Criteria
January 5, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 112180-E
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysteroscopic Myomectomy
-
Assuta Ashdod HospitalAssuta Medical CenterNot yet recruiting
-
Far Eastern Memorial HospitalRecruitingHysteroscopic MyomectomyTaiwan
-
Ain Shams UniversityNot yet recruitingLAZMAR Scoring , Hysteroscopic Myomectomy
-
University of JordanCompletedHysteroscopic Metroplasty and Myomectomy
-
The Fourth Affiliated Hospital of Zhejiang University...Active, not recruitingHysteroscopic MyomectomyChina
-
Far Eastern Memorial HospitalCompletedHysteroscopic SurgeryTaiwan
-
Peking University Shenzhen HospitalEnrolling by invitation
-
Wake Forest University Health SciencesNorth Carolina Biotechnology CenterTerminatedHysteroscopic SurgeryUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
Peking University Third HospitalNot yet recruitingHysteroscopic Surgery | Etomidate Induced Dose
Clinical Trials on Gravity infusion
-
Seoul National University HospitalActive, not recruitingNutrition DisordersKorea, Republic of
-
Shirley Ryan AbilityLabUnknownKnee OsteoarthritisUnited States
-
Cairo UniversityUnknownSpastic Diplegia Cerebral PalsyEgypt
-
NYU Langone HealthCompletedStroke | Post-Stroke HemiparesisUnited States
-
University Medicine GreifswaldCompletedHealthy VolunteersGermany
-
Qassim UniversityCompleted
-
University of LeipzigCompletedRehabilitation | Weight-bearing
-
Carrick Institute for Graduate StudiesWithdrawnShoulder PainUnited States
-
Major Extremity Trauma Research ConsortiumUnited States Department of DefenseCompletedPilon Fracture | Tibial Plateau Fracture | Distal Femur Fracture | Distal Tibia FractureUnited States
-
Helsinki University Central HospitalCompletedRadiation ExposureFinland